Lung Cancer Clinical Trials in Phoenix, AZ

Lung Cancer Clinical Trials in Phoenix, AZ

View the best 10 lung cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Lung Cancer clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for lung cancer in Phoenix, Arizona

Image of Arizona Oncology Assoc, Pc-Hal in Phoenix, United States.

Pemetrexed +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a new way to treat lung cancer that may be more effective and have fewer side effects than the current standard of care.
Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of University of Alabama at Birmingham Comprehensive Cancer Center in Birmingham, United States.

NovoTTF-200M device

Device

Recruiting2 awardsPhase 3
This trial tests a device to treat brain metastases in advanced NSCLC patients, comparing it to the current standard of care.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of Honor Health Research Institute in Scottsdale, United States.

Dabrafenib +1 More

Protein Kinase Inhibitor

Recruiting3 awardsPhase 4
This trial is to provide access for patients who have completed a Novartis or former GSK-sponsored study and are judged by the investigator as benefiting from continued treatment.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Pemetrexed +1 More

Anti-metabolites

Recruiting2 awardsPhase 3
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing the side effects of two immunotherapies, durvalumab and tremelimumab, in combination with high or low-dose radiation therapy, in treating patients with metastatic colorectal or non-small cell lung cancer.
Image of Research Site in Scottsdale, United States.

Tremelimumab +1 More

Checkpoint Inhibitor

Recruiting0 awardsPhase 2
This trial is testing a new cancer drug for people with mesothelioma who can't have surgery. 564 people will be enrolled and randomly assigned to either receive the drug or a placebo. There will be follow-ups to check safety and long-term effects.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.